Latest News

Please view the latest news articles from across Europe below. Alternatively, filter by news category or search by keyword.

#Time4Change: Europe

Published on 30 March 2018 back to previous

In terms of the overall picture in in Europe, colorectal cancer is still the second most common cause of cancer death in both men and women. It is the second most common form of cancer in women, after breast cancer, and the third most common in men, after lung and prostate cancer.3

Although the situation is improving overall, with screening rates increasing and mortality rates dropping in several countries, there are still considerable disparities across Europe. Awareness, knowledge, screening, treatment, access and care – all of these vary considerably from country to country.

#Time4Change – everyone deserves the right to early detection and treatment

EuropaColon is proud to work with its Affiliates and Associates all over Europe to prioritise and raise the profile of colorectal cancer and other digestive cancers in Europe. 

ECCAM is a vital part of that. In 2008 EuropaColon established the month of March as European Colorectal Cancer Awareness Month as an annual awareness raising initiative. A lot has been achieved in the past 10 years, but there is still so much to be done. It is #Time4Change.

“Seeing the reports from each country over the last few weeks has highlighted the huge disparities all over Europe, in particular around the lack of early screening in many countries,” said Jola Gore-Booth, CEO and Founder of EuropaColon. “It can be frustrating, because we know colorectal cancer is preventable in many cases. With a high-quality screening programme in place and sufficient participation, many, many deaths can be avoided.

However, this past month has also highlighted some of the major progress that is going on in several countries to tackle this disease, and some of the incredible work going on by our member organisations and other patient organisations, to make a real, meaningful difference to the lives of people with colorectal cancer. This leaves me feeling positive that, if we take a coordinated approach – which means constantly staying in touch with our European neighbours, comparing and learning from each country’s progress and best practices – that we will start moving towards a Europe with a more equal, fair, high quality approach to screening, diagnosing and treating colorectal cancer. We believe it is #Time4Change to achieve this – let us join forces, speak with one voice, and make it happen.”

 

References

  1. https://www.royalmarsden.nhs.uk/your-care/cancer-types/gastrointestinal/lower-gastrointestinal/colorectal-cancer
  2. https://www.theguardian.com/society/2017/feb/22/new-screening-test-cuts-bowel-cancer-risk-study
  3. www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/news/news/2012/2/early-detection-of-common-cancers/colorectal-cancer

Registration No: 5314195 Registered Office: 92 Palatine Road, London N16 8ST.